Araris Biotech AG

Araris Biotech AG is at the forefront of biotechnology research, specializing in building innovative antibody-drug conjugates (ADCs). With a focus on pioneering novel linker technology, Araris Biotech AG enables the attachment of diverse payloads to readily available antibodies, eliminating the need for prior antibody engineering. This groundbreaking approach promises to revolutionize targeted therapies and enhance treatment outcomes.

Located at Riedhofstrasse 11, Au, ZH 8804, CH, Araris Biotech AG is dedicated to advancing the field of ADCs through cutting-edge research and development. The company's commitment to innovation and excellence positions it as a key player in the biotechnology sector, driving progress and shaping the future of precision medicine. Araris Biotech AG is committed to continuous improvement, and further details about the company's strategic direction will be completed soon with the support of the company’s management.

We invite the manager of Araris Biotech AG to create a customized and exclusive company showcase and product listing on our platform, highlighting the unique capabilities and contributions of Araris Biotech AG to the biotechnology landscape.